Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Bronchiectasis Clinical Trials
Bronchiectasis clinical trials are recruiting across 43 cities. Here are the cities with the most active studies:
About Bronchiectasis
Bronchiectasis is a chronic condition where the bronchial tubes of the lungs are permanently widened, leading to a buildup of mucus and repeated infections. It can result from various causes including infections and genetic conditions. Treatment includes airway clearance, antibiotics, and anti-inflammatory medications.
Clinical trials are advancing new treatments for bronchiectasis. Currently, 15 studies are recruiting a combined 10,445 participants across the United States. Research is being conducted by 13 organizations including COPD Foundation, Boehringer Ingelheim, NYU Langone Health and 10 others.
2026 Bronchiectasis Research Landscape
As of July 2026, the bronchiectasis clinical trial landscape includes 15 actively recruiting studies across 43 cities in the United States. These studies are collectively seeking 10,445 participants, with an average enrollment target of 696 per study.
Research is being led by 13 different organizations, including COPD Foundation, Boehringer Ingelheim, NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI), GlaxoSmithKline, and 8 others. The large number of sponsors reflects significant research interest and investment in bronchiectasis treatment advancement.
Geographically, bronchiectasis trials are most concentrated in Washington D.C., District of Columbia (3 trials); Birmingham, Alabama (3 trials); Denver, Colorado (3 trials); Plantation, Florida (3 trials); Jacksonville, Florida (3 trials) and 7 other cities.
Featured Bronchiectasis Studies
Highlighted recruiting studies for bronchiectasis, selected by enrollment size and research scope.
Bronchiectasis and NTM Research Registry
The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions.
The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
This study is open to adults with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find out whether a medicine called BI 1291583 helps people with bronchiectasis. Participants are put into 2 groups randomly, which means by chance. One group takes BI 1291583 tablets and the other group ta...
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
A biomarker cohort study design is proposed to study whether specific airway microbiota alterations are associated with pulmonary Non-tuberculous mycobacteria (NTM) disease. In a cohort of 200 subjects suspected of having pulmonary NTM disease, the investigators will evaluate the airway microbiome using an aliquot of the induced sputum and upper airway samples. Since induced sputum may reflect dif...
Frequently Asked Questions About Bronchiectasis Clinical Trials
Are there bronchiectasis clinical trials near me?
Yes, there are 15 bronchiectasis clinical trials currently recruiting across 43+ cities in the United States, including Washington D.C., District of Columbia; Birmingham, Alabama; Denver, Colorado. Browse the studies above to find one at a location convenient for you.
How do I join a bronchiectasis clinical trial?
To join a bronchiectasis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are bronchiectasis clinical trials free?
Yes, participation in bronchiectasis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of bronchiectasis treatments are being studied?
Current bronchiectasis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 13 research organizations.
Is it safe to participate in bronchiectasis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 13, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 13, 2026 · Data from ClinicalTrials.gov